Global funding for neglected disease R&D hit record high in 2017 — with meaty contributions by UK, EC, India and Germany
About a decade ago, in the throes of the global financial crisis when most countries focused their resources on stimulating their domestic economies, the United States’ NIH overwhelmingly contributed to global funding for neglected disease R&D. But other nations are now catching up. In 2017, global investment for neglected diseases hit record levels at $3.5 billion — the largest increase since 2008 — driven largely by the UK and the European Commission (EC), along with India and Germany, according to a key survey funded by the Bill and Melinda Gates Foundation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
